Literature DB >> 9484662

Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy.

A Saitoh1, Y Suzuki, M Takeda, K Kubota, K Itoh, Y Tomino.   

Abstract

Using a quantitative sandwich ELISA, we studied 17 patients with IgA nephropathy to determine if levels of urinary monocyte chemoattractant protein-1 (MCP-1) might reflect the disease activity. The levels of urinary MCP-1 in patients with the advanced stage were significantly higher than those in patients with the mild stage of the disease, or in healthy controls. The results showed a significant correlation between the levels of urinary MCP-1 and the disease activity, i.e., levels of urinary casts and urinary protein. It was thus suggested that the measurement of urinary MCP-1 is useful in evaluating the degree of renal injuries and/or prognosis in patients with IgA nephropathy.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9484662      PMCID： PMC6808122          DOI： 10.1002/(sici)1098-2825(1998)12:1<1::aid-jcla1>3.0.co;2-f

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN： 0887-8013            Impact factor:   2.352


  17 in total

1.  [Intercapillary deposits of IgA-IgG].

Authors:  J Berger; N Hinglais
Journal:  J Urol Nephrol (Paris)       Date:  1968-09

2.  Interstitial immune complex nephritis in patients with systemic lupus erythematosus.

Authors:  J R Brentjens; M Sepulveda; T Baliah; C Bentzel; B F Erlanger; C Elwood; M Montes; K C Hsu; G A Andres
Journal:  Kidney Int       Date:  1975-05       Impact factor: 10.612

3.  Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.

Authors:  B H Rovin; M Rumancik; L Tan; J Dickerson
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

4.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.

Authors:  M W Carr; S J Roth; E Luther; S S Rose; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Expression of intercellular adhesion molecule-1 and infiltration of lymphocytes in glomeruli of patients with IgA nephropathy.

Authors:  Y Tomino; H Ohmuro; T Kuramoto; I Shirato; K Eguchi; H Sakai; K Okumura; H Koide
Journal:  Nephron       Date:  1994       Impact factor: 2.847

6.  Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells.

Authors:  J A Satriano; K Hora; Z Shan; E R Stanley; T Mori; D Schlondorff
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

7.  Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis.

Authors:  M Noris; S Bernasconi; F Casiraghi; S Sozzani; E Gotti; G Remuzzi; A Mantovani
Journal:  Lab Invest       Date:  1995-12       Impact factor: 5.662

8.  Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.

Authors:  R A Stahl; F Thaiss; M Disser; U Helmchen; K Hora; D Schlöndorff
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

9.  Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.

Authors:  D D Taub; P Proost; W J Murphy; M Anver; D L Longo; J van Damme; J J Oppenheim
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy.

Authors:  Y Tomino; K Funabiki; H Ohmuro; M Shimizu; K Yokoyama; I Shirato; T Shirai; M Takahashi; H Koide
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754
View more
  10 in total

1.  Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.

Authors:  Kumiko Nishihara; Satohiro Masuda; Haruka Shinke; Aiko Ozawa; Takaharu Ichimura; Atsushi Yonezawa; Shunsaku Nakagawa; Ken-Ichi Inui; Joseph V Bonventre; Kazuo Matsubara
Journal:  Biochem Pharmacol       Date:  2013-01-02       Impact factor: 5.858

2.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

3.  Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy.

Authors:  F Huang; S Horikoshi; A Kurusu; T Shibata; S Suzuki; K Funabiki; I Shirato; Y Tomino
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

Authors:  Kyouichi Tashiro; Ichiro Koyanagi; Akemi Saitoh; Ayumi Shimizu; Toshihide Shike; Chizuru Ishiguro; Michiko Koizumi; Kazuhiko Funabiki; Satoshi Horikoshi; Isao Shirato; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

5.  Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE.

Authors:  Piotr Piotrowski; Margarita Lianeri; Robert Gasik; Andrzej Roszak; Marzena Olesińska; Paweł P Jagodziński
Journal:  J Biomed Biotechnol       Date:  2010-04-21

6.  Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.

Authors:  Tatsuyuki Inoue; Hitoshi Sugiyama; Masashi Kitagawa; Keiichi Takiue; Hiroshi Morinaga; Ayu Ogawa; Yoko Kikumoto; Shinji Kitamura; Yohei Maeshima; Hirofumi Makino
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

7.  Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.

Authors:  P Launay; B Grossetête; M Arcos-Fajardo; E Gaudin; S P Torres; L Beaudoin; N Patey-Mariaud de Serre; A Lehuen; R C Monteiro
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

Review 8.  The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy : Gene involvement in the mechanisms of inflammation and scarring in kidney biopsy of IgAN patients.

Authors:  Francesco Paolo Schena; Michele Rossini; Daniela Isabel Abbrescia; Gianluigi Zaza
Journal:  Semin Immunopathol       Date:  2021-10-21       Impact factor: 9.623

9.  Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy.

Authors:  Masashi Aizawa; Yusuke Suzuki; Hitoshi Suzuki; Huihua Pang; Masao Kihara; Junichiro Nakata; Kenji Yamaji; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

10.  Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy.

Authors:  Shuntaro Maruyama; Tomohito Gohda; Yusuke Suzuki; Hitoshi Suzuki; Yuji Sonoda; Saki Ichikawa; Zi Li; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Kidney Res Clin Pract       Date:  2016-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.